首页> 美国卫生研究院文献>Frontiers in Genetics >Alternative end-joining mechanisms: a historical perspective
【2h】

Alternative end-joining mechanisms: a historical perspective

机译:替代性的末端连接机制:历史观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the presence of functional DNA repair pathways, DNA double-strand breaks (DSBs) are mainly repaired by non-homologous end-joining (NHEJ) or homologous recombination (HR), two conserved pathways that protect cells from aberrant chromosomal rearrangements. During the past two decades however, unusual and presumably distinct DNA end-joining repair activities have been unraveled in NHEJ-deficient cells and these are likely to operate in various chromosomal contexts and species. Most alternative DNA end-joining events reported so far appear to involve microhomologous sequences and are likely to rely on a subset of HR enzymes, namely those responsible for the single-strand annealing mechanism of HR, and on DNA Ligase III. Usually, microhomologies are not initially present at DSB ends and thus need to be unmasked through DNA end resection, a process that can lead to extensive nucleotide loss and is therefore highly mutagenic. In addition to microhomology-mediated end-joining events, recent studies in mammalian cells point toward the existence of a distinct and still ill defined alternative end-joining pathway that does not appear to rely on pre-existing microhomologies and may possibly involve DNA Ligase I. Whether dependent on microhomologies or not, alternative DNA end-joining mechanisms are likely to be highly mutagenic in vivo, being able to drive telomere fusion events and cancer-associated chromosomal translocations in mouse models. In the future, it will be important to better characterize the genetic requirements of these mutagenic alternative mechanisms of DNA end-joining.
机译:在存在功能性DNA修复途径的情况下,DNA双链断裂(DSB)主要通过非同源末端连接(NHEJ)或同源重组(HR)进行修复,这是两个保守的途径,可以保护细胞免受异常的染色体重排。然而,在过去的二十年中,在NHEJ缺陷型细胞中未发现异常且推测不同的DNA末端连接修复活性,这些活性可能在各种染色体背景和物种中起作用。迄今为止报道的大多数替代性DNA末端连接事件似乎都涉及微同源序列,并且可能依赖于HR酶的一个子集,即那些负责HR单链退火机制的酶和DNA Ligase III。通常,微同源性最初并不存在于DSB末端,因此需要通过DNA末端切除来掩盖,该过程可能导致大量核苷酸丢失,因此具有很高的致突变性。除了微同源性介导的末端连接事件外,哺乳动物细胞中的最新研究还指出,存在着一个独特且仍未明确定义的替代性末端连接途径,该途径似乎并不依赖于先前存在的微同源性,并且可能涉及DNA Ligase I不管是否依赖于微同源性,替代的DNA末端连接机制在体内可能都是高度致突变的,能够在小鼠模型中驱动端粒融合事件和与癌症相关的染色体易位。将来,重要的是更好地表征DNA末端连接的这些诱变替代机制的遗传要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号